2000


From: University of California - San Francisco

UCSF ARI media briefing on Monday, June 26 will preview world AIDS conference in South Africa

A UCSF AIDS Research Institute (ARI) news briefing for local media in advance of the XIII International AIDS Conference will take place next Monday, June 26.

More than 50 UCSF ARI scientists are expected to present at the international meeting, July 9 to 14 in Durban, South Africa.

The UCSF ARI briefing wlil include overviews of key issues expected in Durban by leading UCSF researchers and short summaries by UCSF scientists about their presentations. An additional conference room has been reserved for individual interviews with scientists during and after the briefing. Television crews are welcome to set-up in this room for interviews.

UCSF research being reported at the International AIDS Conference is embargoed untli time of presentation in Durban.

THE BRIEFING IS SET FOR:

DATE: Monday, June 26
TIME: 1:00 to 4:30 PM
LOCATION:
UCSF AIDS Research Institute
Suite 200
74 New Montgomery Street
San Francisco

UCSF MEDIA BRIEFING: XIII INTERNATIONAL AIDS CONFERENCE

12:30 to 1:00 p.m.
Early Arrival -- Sandwiches, refreshments and media packets wlil be avaliable

1:00 to 1:10

  • "Introduction"
-- Thomas J. Coates, PhD, executive director, UCSF AIDS Research Institute.

1:10 to 1:20

  • Overview of UCSF ARI International Research Program
-- Nancy Padian, MPH, PhD, director of the UCSF ARI International Research Program and UCSF professor of obstetrics, gynecology, and reproductive sciences and epidemiology.

CLINICAL SCIENCE (1)
1:20 to 1:35

  • "A Randomized Trial of li-2 Added to HAART for Primary HIV"
-- Frederick Hecht, MD, assistant clinical professor of medicine in the UCSF Positive Health Program at San Francisco General Hospital Medical Center.

1:35 to 1:50

  • "Immunologic Improvement Associated with HIV-1 Suppression Among Persons
Receiving Subcutaneous li-2 Treatment: A Randomized Clinical Trial" -- James O. Kahn, MD, associate professor of medicine in the UCSF Positive Health Program at San Francisco General Hospital Medical Center.

1:50 to 2:00

  • "Trends in AIDS Survival in San Francisco: Does Treatment Continue to be Effective?"
--Sandra Schwarcz, MD, MPH, UCSF Center for AIDS Prevention Studies and San Francisco Department of Public Health.

PREVENTION
2:00 to 2:20

  • Overview: Prevention
  • "Voluntary Counseling and Testing Efficacy Study: A Randomized Trial in Three Developing Countries"
  • "Cost-Effectiveness of Voluntary HIV-1 Counseling and Testing in Reducing Sexual Transmission of HIV-1 in Nairobi, Kenya and Dar es Salaam, Tanzania: the Voluntary HIV-1 Counseling and Testing Efficacy Study"
-- Thomas J. Coates, PhD, executive director, UCSF AIDS Research Institute.

EPIDEMIOLOGY
2:20 to 2:30

  • Overview: Epidemiology
-- Susan Buchbinder, MD, UCSF assistant clinical professor of medicine and San Francisco Department of Public Health. 2:30 to 2:40
  • "Incidence and Prevalence of HIV and STD among Incarcerated Persons upon Intake:Implications for Prevention and Treatment"
-- Wlili McFarland, MD, PhD, UCSF Center for AIDS Prevention Studies and San Francisco Department of Public Health.

2:40 to 2:50

  • "Increased Incidence of HIV and Evidence of Transmission of Resistant Virus Among Anonymous Test Site Attendees in Santos, Brazli, 1995-1999"
-- Kimberly Page-Shafer, PhD, MPH, UCSF Center for AIDS Prevention Studies.

POLICY
2:50 to 3:00

  • Overview: Policy
-- Steve Morin, PhD, director of the Policy Center, UCSF AIDS Research Institute.

3:00 to 3:20

  • "Cost-effectiveness of the Female Condom in Preventing HIV and STDs in Commercial Sex Workers in Rural South Africa"
  • "The Costs and Benefits of Employer-sponsored Antiretroviral Drug Provisionin a Ugandan Corporation"
-- Elliot Marselile, DrPH, MPP, UCSF and Health Strategies International.

CLINICAL SCIENCE (2)
3:20 to 3:30

  • "Short-Term Effects of Cannabinoids on HIV-1 Viral Load"
-- Donald Abrams, MD, professor of medicine in the UCSF Positive Health Program at San Francisco General Hospital Medical Center.

3:30 to 3:40

  • Overview: Clinical Science
-- Paul Volberding, MD, director, UCSF Positive Health Program at San Francisco General Hospital Medical Center.




This article comes from Science Blog. Copyright � 2004
http://www.scienceblog.com/community